EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Accuracy of cell‐free fetal DNA in detecting chromosomal anomalies in women experiencing miscarriage: systematic review and meta‐analysis

L Della Valle iD, M Piergianni iD, A Khalil iD, G Rizzo iD, I Mappa, B Matarrelli, A Lucidi iD, L Manzoli, M E Flacco iD, L Stuppia, F D'Antonio iD

Ultrasound in Obstetrics & Gynecology · 2025

DOI: 10.1002/uog.29131 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Ultrasound in Obstetrics & Gynecology, 2025. Verfasst von L Della Valle und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Fetal Care and High-Risk Pregnancy, University of Chieti, Chieti, Italy. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids, Sensitivity and Specificity, Abortion, Spontaneous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To report the diagnostic accuracy of cell‐free fetal DNA (cfDNA) in detecting fetal chromosomal anomalies in women experiencing miscarriage.

Methods

PubMed, MEDLINE, EMBASE and Cochrane databases were searched from inception to June 2024. The inclusion criteria were women experiencing miscarriage (defined as pregnancy loss before 20 weeks of gestation) who underwent cfDNA screening for trisomies 21, 18 and 13, other autosomal aneuploidies, sex‐chromosome aneuploidies and/or copy‐number variants (CNVs). The index test was cfDNA screening for each of the chromosomal anomalies listed. The reference standard was cytogenetic analysis of pregnancy tissue. The quality of the studies was assessed using the revised tool for the quality assessment of diagnostic accuracy studies. Summary estimates of sensitivity, specificity, positive and negative likelihood ratios, and diagnostic odds ratio were computed using the hierarchical summary receiver‐operating‐characteristics model.

Results

Seven studies (887 women) were included in the systematic review and meta‐analysis. cfDNA had a sensitivity and specificity of 100% (95% CI, 81.5–100%) and 100% (95% CI, 99.1–100%), respectively, for trisomy 21, 100% (95% CI, 54.1–100%) and 100% (95% CI, 99.0–100%), respectively, for trisomy 18, and 88.9% (95% CI, 51.8–99.7%) and 100% (95% CI, 99.1–100%), respectively, for trisomy 13. The respective values for other autosomal trisomies were 75.8% (95% CI, 65.7–84.2%) and 99.4% (95% CI, 97.9–99.9%), while those for CNVs were 60.0% (95% CI, 14.7–94.7%) and 100% (95% CI, 97.4–100%). Failure of cfDNA testing was reported in 7.3% (95% CI, 5.7–9.2%) of cases. Conclusion cfDNA has high diagnostic accuracy in detecting fetal trisomies 21, 18 and 13 in women experiencing miscarriage, while its accuracy for other autosomal aneuploidies and CNVs is only moderate. © 2024 International Society of Ultrasound in Obstetrics and Gynecology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell-Free Nucleic AcidsSensitivity and SpecificityAbortion, SpontaneousHumansFemalePregnancyChromosome DisordersChromosome AberrationsDNA Copy Number VariationsTrisomy 18 SyndromeTrisomy 13 SyndromeNoninvasive Prenatal TestingDown Syndrome

Stichwörter der Autor:innen

aneuploidycell‐free fetal DNAcfDNAmiscarriagetrisomy

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • Center for Fetal Care and High-Risk Pregnancy, University of Chieti, Chieti, Italy.
  • Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, University of London, London, UK.
  • Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.
  • Twins Trust Centre for Research and Clinical Excellence, St George's University Hospital, St George's University of London, London, UK.
  • Fetal Medicine Unit, Liverpool Women's Hospital, University of Liverpool, Liverpool, UK.
  • Department of Obstetrics and Gynecology, Università Tor Vergata, Roma, Italy.

ORCID-Profile: L Della Valle, M Piergianni, A Khalil, G Rizzo, A Lucidi, M E Flacco, F D'Antonio

Zitieren

APA

Della Valle, L., Piergianni, M., Khalil, A., Rizzo, G., Mappa, I., Matarrelli, B., Lucidi, A., Manzoli, L., Flacco, M. E., Stuppia, L., & D'Antonio, F. (2025). Accuracy of cell‐free fetal DNA in detecting chromosomal anomalies in women experiencing miscarriage: systematic review and meta‐analysis. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.29131

Vancouver

Della Valle L, Piergianni M, Khalil A, Rizzo G, Mappa I, Matarrelli B, et al. Accuracy of cell‐free fetal DNA in detecting chromosomal anomalies in women experiencing miscarriage: systematic review and meta‐analysis. Ultrasound in Obstetrics & Gynecology. 2025. doi:10.1002/uog.29131

BibTeX
@article{DellaValle2025,
  author = {Della Valle, L and Piergianni, M and Khalil, A and Rizzo, G and Mappa, I and Matarrelli, B and Lucidi, A and Manzoli, L and Flacco, M E and Stuppia, L and D'Antonio, F},
  title = {Accuracy of cell‐free fetal DNA in detecting chromosomal anomalies in women experiencing miscarriage: systematic review and meta‐analysis},
  journal = {Ultrasound in Obstetrics & Gynecology},
  year = {2025},
  doi = {10.1002/uog.29131}
}
Kostenlos starten →